Western Blot (WB)
(Western blot analysis of extracts of various cell lines, using CPA6 antibody at 1:1000 dilution.)
Rabbit CPA6 Polyclonal Antibody | anti-CPA6 antibody
CPA6 Polyclonal Antibody
PBS with 0.02% sodium azide, 50% glycerol, pH7.19
IHC: 1:50-1:200
IF: 1:50-1:200
Western Blot (WB)
(Western blot analysis of extracts of various cell lines, using CPA6 antibody at 1:1000 dilution.)
Western Blot (WB)
(Western blot analysis of extracts of various cell lines, using CPA6 antibody at 1:1000 dilution.)
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded rat brain using CPA6 antibody at dilution of 1:100 .)
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded rat brain using CPA6 antibody at dilution of 1:100 .)
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded human liver using CPA6 antibody at dilution of 1:100 .)
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded human liver using CPA6 antibody at dilution of 1:100 .)
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded mouse brain using CPA6 antibody at dilution of 1:100 .)
Immunohistochemistry (IHC)
(Immunohistochemistry of paraffin-embedded mouse brain using CPA6 antibody at dilution of 1:100 .)
NCBI and Uniprot Product Information
NCBI Description
The protein encoded by this gene belongs to the family of carboxypeptidases, which catalyze the release of C-terminal amino acid, and have functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Polymorphic variants and a reciprocal translocation t(6;8)(q26;q13) involving this gene, have been associated with Duane retraction syndrome.[provided by RefSeq, Sep 2010]
Uniprot Description
CPA6: May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II. A chromosomal aberration involving CPA6 was found in a patient with Duane retraction syndrome. Translocation t(6;8)(q26;q13). Defects in CPA6 are the cause of epilepsy, familial temporal lobe, type 5 (ETL5). ETL5 is a focal form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe. Seizures are usually accompanied by sensory symptoms, most often auditory in nature. Defects in CPA6 are the cause of familial febrile convulsions type 11 (FEB11). FEB11 consists of seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Belongs to the peptidase M14 family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Secreted, signal peptide; EC 3.4.17.1; Secreted; Protease
Chromosomal Location of Human Ortholog: 8q13.2
Cellular Component: proteinaceous extracellular matrix
Molecular Function: zinc ion binding; metallocarboxypeptidase activity
Biological Process: proteolysis
Disease: Epilepsy, Familial Temporal Lobe, 5; Febrile Seizures, Familial, 11
Research Articles on CPA6
Similar Products
Product Notes
The CPA6 cpa6 (Catalog #AAA9457667) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The CPA6 Polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. AAA Biotech's CPA6 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF). WB: 1:500-1:2000 IHC: 1:50-1:200 IF: 1:50-1:200. Researchers should empirically determine the suitability of the CPA6 cpa6 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "CPA6, Polyclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
